Pharmacy Education 2018 Speakers

Boston Harbor Skyline

Opening General Session

How to be Happy at Work: The Power of Purpose, Hope and Friendship

Annie McKee, Ph.D.

Best-selling author, academic and speaker Annie McKee is a sought-after advisor to leaders of Fortune 500 companies, governments and NGOs around the globe. She has co-authored groundbreaking Harvard Business Review books on the power of emotional intelligence to change how we lead and engage with one another. 

A Senior Fellow at the University of Pennsylvania, Dr. McKee teaches and leads the PennCLO Executive Doctoral Program and the Penn MedEd Master’s program, as well as teaching at the Wharton School’s Aresty Institute of Executive Education. Dr. McKee’s book, How to be Happy at Work: The Power of Purpose, Hope and Friendship delivers a hands-on guide with practical exercises and instructions for how to be happy at work—no matter what job you have. 

At the Opening General Session, McKee will share vivid and moving real-life stories that illustrate how to use purpose, hope, and friendship to create and sustain happiness and ensure a healthy, positive climate for teams and throughout organizations. Annie is committed to helping good leaders become better and to creating vibrant workplace cultures where people and their institutions thrive.


Science Plenary 

Sex as a Biological Variable in Drug Approval: Translation to Pharmacy Education

Marjorie Jenkins, M.D.

Join Dr. Marjorie Jenkins and Dr. Rebecca Sleeper as they provide an overview of the regulatory history of the inclusion of women in research activities and clinical trials, discuss the evaluation of potential sex differences in preclinical review throughout drug development, as well as in clinical review of investigational new drugs (INDs) and new drug applications (NDAs). The importance of expanding women’s health education beyond reproductive health will be addressed. The session will conclude with a discussion of resources and models available to integrate clinically relevant sex and gender evidence into pharmacy school curricula.

Dr. Jenkins joined the FDA Office of Women’s Health (OWH) in 2015. In her role as OWH director of medical initiatives and scientific engagement, Dr. Jenkins provides sex and gender science expertise within research, health education, and communications programs.

Rebecca Sleeper, Pharm.D.

Dr. Sleeper joined the TTUHSC SOP faculty in 1999 and is currently a professor of pharmacy practice in the geriatrics division and is the associate dean of curriculum for the school. At the Health Sciences Center level she also serves as the vice chair for the TTUHSC Institutional Review Board, and is a member of the TTUHSC Sex and Gender Specific Health program.


Tuesday General Session

The Opioid Crisis: Made in America...Fade in America?

Bertha Madras, Ph.D.

In the Tuesday General Session, Dr. Bertha Madras will describe the root causes of the opioid epidemic, including the role of private and government entities that failed to protect the public. Strategies to reverse the root causes, including those that can be addressed by government funding, government regulations and the criminal justice system alone cannot reverse the tide. As healthcare systems become increasingly engaged, the potential of pharmacists to make a positive difference is significant.

Dr. Madras is a professor of psychobiology at Harvard Medical School (HMS), and with a cross-appointment at the Massachusetts General Hospital in Boston. As an HMS faculty member and neuroscientist for 30 years, her research on psychoactive or therapeutic drugs, brain imaging, and others is published in more than 200 manuscripts, articles, books, book chapters and commentaries.

On a national level, she currently serves as a key member of the President’s Commission on Combating Drug Addiction and the Opioid Crisis. Formerly, she was appointed deputy director for demand reduction (prevention, intervention treatment) in the White House Office of National Drug Control Policy, Executive Office of President, a presidential nomination confirmed unanimously by the U.S. Senate.